This Article Full Text (PDF) All Versions of this Article: 0269881107083998v1 23/1/106    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hung, G.-L Articles by Chen, Y-Y. Search for Related Content PubMed PubMed Citation Articles by Hung, G.-L Articles by Chen, Y-Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CLOZAPINE Medline Plus Health Information Schizophrenia Social Bookmarking                         What's this?

Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient

Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan

Y-Y. Chen

Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan; Institute of Public Health and Department of Social Medicine, National Yang Ming University, Taipei, Taiwan, ychen{at}tpech.gov.tw, catriona.cordelia{at}gmail.com

Aripiprazole, a partial dopaminergic agonist, represents a well-tolerated and effective addition to the antipsychotic armamentarium. However, accumulated data indicates that aripiprazole may still induce extrapyramidal side effects (EPS) in susceptible patients. Guidelines for treating schizophrenia have consistently recommended antipsychotic monotherapy. Nevertheless, in certain clinical situations, a thorough evaluation of the benefit/risk ratio suggests that combinations of antipsychotic agents may improve treatment efficacy and tolerability. We report a schizophrenic patient for whom sequential administration of aripiprazole and risperidone induced severe EPS, and subsequent combination therapy with of clozapine and aripiprazole achieved adequate symptom control and markedly reduced EPS.

Key Words: aripiprazole • extrapyramidal side effects • clozapine • polypharmacy

This version was published on January 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 1, 106-108 (2009)
DOI: 10.1177/0269881107083998


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?